Lenacapavir/Islatravir

N/A

Report date: 2025/01/15 10:22:53

Base Information

Drug NameLenacapavir/Islatravir
Drug Alias NameMK-8591D
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionCapsid protein inhibitorsReverse transcriptase inhibitors
TargetsCapsid proteinReverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesTaiwan +[16] 
CombinationsYes Lenacapavir sodiumIslatravir
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences IncMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesEva PharmaGilead Sciences IncMerck & Co Inc +[4] 
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A